Delivery Order SPE2DB20D7059-SPE2DB25FQGM3

Award Date 5/15/25
Potential Completion Date 5/16/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for $1,228.50 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,752,767 units of Methylphenidate 2.5 mg chewable tablets in 100-count packages, with a completion date of December 19, 2024. This contract award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $3,534.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,239,251 units of methylphenidate 2.5 mg chewable tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of May 14, 2025 and is a firm fixed-price delivery order, with no set-aside designation....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,502,453 units of methylphenidate ER 18 mg tablets in 100-count bottles. The $1,519.44 firm fixed-price Delivery Order (DO) has a completion date of November 21, 2024 and is not subject to any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,510,706 units of Methylphenidate ER 18 mg tablets in 100-count packages. The Firm Fixed Price contract, valued at $1,613.35, has a completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,328,498 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $5,068.82 firm-fixed-price delivery order has a completion date of November 5, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.60, is a delivery order for 4,567,988,230 units of the drug Methylphenidate ER 18 mg Tablets in 100-count bottles. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award, valued at $8,219.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,564,739,444 units of 10 mg Methylphenidate chewable tablets. The contract has an ultimate completion date of May 30, 2024 and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
The U.S. government awarded a Delivery Order (contract) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide 4,564,891,468 units of Methylphenidate 2.5 mg chewable tablets in 100-count bottles. The contract, valued at $1,053.00, has a firm-fixed price and an ultimate completion date of June 13, 2024. Amerisourcebergen, through its Corporate Office division, is an experienced supplier of a wide range of pharmaceutical products and medical supplies to various...
This federal contract award is for the delivery of 4,563,338,055 units of Methylphenidate 5 mg chewable tablets in 100 count bottles. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The firm fixed price delivery order has a potential value of $1,916.30 and will be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was used for...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB25FQGM3
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,568,254,588 units of Methylphenidate 2.5 mg chewable tablets in 100-count bottles. The $1,755.00 firm fixed-price delivery order is a non-set-aside award, meaning it was open to full and open competition. The contract has an ultimate completion date of May 16, 2025. Amerisourcebergen Drug Corp is a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems, through its substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026.

Generated 8/17/25, 12:57 AM